Stay updated on KTE-C19 + Atezolizumab in DLBCL Clinical Trial
Sign up to get notified when there's something new on the KTE-C19 + Atezolizumab in DLBCL Clinical Trial page.

Latest updates to the KTE-C19 + Atezolizumab in DLBCL Clinical Trial page
- CheckyesterdayChange DetectedThe page displays a new revision stamp v3.6.3, replacing the previous v3.6.2.SummaryDifference0.0%

- Check8 days agoChange DetectedPage revision updated from v3.6.0 to v3.6.2, indicating a minor platform update. This change does not modify study details, eligibility criteria, locations, or user-facing content.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page now displays that recruitment has ended, and new help sections such as How to Read a Study Record, Common Questions, and How to Join a Study have been added; the Intervention / Treatment label formatting has been updated to Intervention/Treatment, and the revision tag updated from v3.5.5 to v3.6.0.SummaryDifference0.3%

- Check29 days agoChange DetectedThe page’s revision indicator was updated from v3.5.4 to v3.5.5, signaling an updated iteration of the page.SummaryDifference0.0%

- Check51 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4, reflecting a version bump to the page metadata. This is a minor update to the page's revision reference and does not alter visible content.SummaryDifference0.0%

- Check73 days agoChange DetectedThe page now shows an updated site/software revision identifier, changing the revision value from v3.5.2 to v3.5.3.SummaryDifference0.0%

Stay in the know with updates to KTE-C19 + Atezolizumab in DLBCL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KTE-C19 + Atezolizumab in DLBCL Clinical Trial page.